When considering the drugs most likely to cause former addicts to repeatedly relapse, opioids, cocaine, and methamphetamine ...

Cocaine addiction isn’t simply a failure of willpower — it’s the result of lasting biological changes in the brain.

Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...

Researchers identify PV neurons in the prefrontal cortex as the gatekeepers of drug addiction relapse, offering a new target for precision treatment.

Mindfulness, holistic care, and neuroscience are reshaping addiction treatment and offering hope for recovery. Mindfulness, holistic care, and neuroscience are reshaping addiction treatment and ...

Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using. Previously, this phenomenon was attributed to a decline ...

Scientists don’t yet fully understand how GLP-1 drugs like Ozempic affect the brain’s reward pathways, but there are ...

When a cocaine addict relapses, it isn't a matter of personal failure—it's the biological result of their brain's rewiring, ...

Methamphetamine addiction has a way of looping back on itself. A rush of pleasure pulls you in, cravings follow, and the brain learns that the drug is the fastest route to reward. Yet scientists still ...

New research suggests that popular GLP-1 weight-loss medications like Ozempic and Wegovy may do more than help people lose weight. Scientists are now investigating an unexpected benefit: these drugs ...

The ‘gray area’ of addiction.